exenatide subdermal implant (Pending FDA Approval)

Brand and Other Names:
  • Print

Dosing & Uses

Diabetes Mellitus, Type 2

Subdermal implant pending FDA approval that provides continuous SC delivery of exenatide for months

Next:

Pharmacology

Mechanism of Action

A glucagonlike peptide-1 (GLP-1) that mimics incretin and promotes insulin secretion, suppresses glucagon, and slows gastric emptying

Previous
Next:

Images

Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.